Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this review, researchers summarize drugs associated with scarring or permanent hair loss, notably after chemotherapy and tyrosine kinase inhibitor treatments, emphasizing the need for stronger evidence and long-term follow-up studies, as current findings are mostly from case reports.

This study conducted on YouTube Shorts videos found that a majority of content related to alopecia recommended treatments that could be carried out independently, such as over-the-counter medications, while professional recommendations by dermatologists comprised less than 15% of the videos but showed high viewer engagement.

In this retrospective cohort study, 87.1% of pediatric patients with chemotherapy-induced alopecia experienced clinical improvement after treatment with minoxidil or combination therapy with CYP, with the combination therapy showing greater hair thickness and minimal adverse effects.

In this research, the authors concluded that the long-term success of hair transplantation for androgenetic alopecia is significantly influenced by how well patients manage their recovery period post-surgery.

This literature review reported that scalp hypothermia significantly decreases the occurrence of chemotherapy-induced alopecia, increasing effectiveness by 2.7-fold in controlled clinical trials and 3.9-fold in randomized trials, and highlighted a need for standard guidelines for its use.

This paper provides an overview of scalp cooling as an effective and safe intervention for preventing chemotherapy-induced alopecia, addressing its impact on cancer patients and survivors.

This review highlights emerging strategies to manage chemotherapy side effects like nausea, neuropathy, and alopecia, noting that scalp cooling has been effective for reducing hair loss, while cryotherapy and cannabis show promise but need further study for side effect management.

This article reviews the pathophysiology of chemotherapy-induced alopecia and reports that scalp cooling can reduce hair loss by 50% in patients with early breast cancer receiving chemotherapy, without compromising survival or increasing scalp metastasis risk.

This paper discusses the introduction and advantages of an Insurance-Based Billing Model for scalp cooling devices in the USA, which can enhance access to this treatment for reducing chemotherapy-induced alopecia, particularly benefiting underserved and disadvantaged populations.

This review discusses the common occurrence of docetaxel-induced hair loss in cancer patients, including permanent cases, and highlights current and experimental strategies like scalp cooling, minoxidil, and new clinical trials for managing and preventing this side effect.

This article discusses various aspects of hair and scalp health, ancient philosophical perspectives on hair, and causes of hair disorders in children, without reporting new clinical results.

This review discusses the potential of low-dose oral minoxidil as a safe and effective treatment for certain hair disorders, including alopecia, but reports no new clinical results.

This article reviews treatment options for female-pattern hair loss, noting the limited evidence for most therapies and emphasizing that topical minoxidil remains the only well-supported option despite a significant non-response rate.

This study found that people with alopecia who worry about not wearing a wig reported higher levels of depression, anxiety, and social anxiety, although wig use increased social confidence for many.

This report describes a sudden hair matting incident after shampooing a hairpiece and suggests that weathered hairs might explain this unusual event.

This article provides a comprehensive guide on wig making, styling, and maintenance techniques but does not report any new research findings.

In this study, a case of a 70-year-old woman with central centrifugal cicatricial alopecia showed that using a high-quality hair prosthesis improved her quality of life and mood, as measured by PHQ-9 and Skindex-29 scores, though such wigs are rarely covered by insurance.

In this study, researchers reviewed wig prescribing practices for alopecia at a single center and found a high demand for wigs, especially acrylic ones, and noted significant funding discrepancies between different regions, emphasizing their importance in managing patient wellbeing on the NHS.

This study surveyed UK healthcare professionals on wig provision for nonprivate patients with severe alopecia, finding significant regional disparities in access and perceived ease, which contradict the Alopecia UK Charter for equitable wig distribution.

This quality improvement initiative at Children’s Hospital of Orange County seeks to increase awareness and use of nonprofit pediatric wig programs by at least 50% over three months through educational interventions.

This case report documents the first instance of frontal fibrosing alopecia where lichen planopilaris developed at wig attachment sites, suggesting wigs may trigger the Koebner phenomenon in affected patients.

Wearing a wig caused a woman's skin condition to worsen due to pressure from the wig's fasteners.

This review discusses synthetic and nonsynthetic wigs for alopecia and reports no new results; it aims to inform physicians on advising patients about available wig options.

This article is a letter to the editor discussing potential therapeutic synergy between a wig-fixing device and tofacitinib for treating alopecia areata but reports no new clinical results.

This paper explores the social challenges individuals with medical hair loss face when using wigs, highlighting the complex identity management involved and the social obligations to disclose wig use to close ones.

This study found that patients with alopecia areata experience significant impairments in health-related quality of life, notably affecting mental health, according to various quality of life assessment tools.

This article updates Japanese guidelines for diagnosing and treating male and female-pattern hair loss, recommending specific drugs and therapies while advising against certain treatments for female-pattern hair loss.

This study aimed to identify sociodemographic and clinical factors affecting quality of life in African-American women with central centrifugal cicatricial alopecia, a primary scarring hair loss condition, as existing literature on quality of life specifically for these patients is scarce.

This article addresses an unusual side effect of azathioprine but provides no abstract or detailed results, focusing instead on a specific dermatological perspective.